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Abstract 
Artificial intelligence (AI) has been hailed as the fourth industrial revolution and its influence 
on people’s lives is increasing. The research on AI applications in medicine is progressing 
rapidly. This revolution shows promise for more precise diagnoses, streamlined workflows, 
increased accessibility to healthcare services and new insights into ever-growing population-
wide datasets. While some applications have already found their way into contemporary 
patient care, we are still in the early days of the AI-era in medicine.  
Despite the popularity of these new technologies, many practitioners lack an understanding of 
AI methods, their benefits, and pitfalls. This review aims to provide information about the 
general concepts of machine learning (ML) with special focus on the applications of such 
techniques in cardiovascular medicine. It also sets out the current trends in research related to 
medical applications of AI. 
Along with new possibilities, new threats arise - acknowledging and understanding them is as 
important as understanding the ML methodology itself. Therefore, attention is also paid to the 
current opinions and guidelines regarding the validation and safety of AI-powered tools. 
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Introduction 
Medical practitioners build their clinical experience when treating thousands of 
patients during their lifetime. However, nobody lives long enough to experience all possible 
variants and cases personally. Moreover, the perception and decision making of physicians 
may vary over time depending on different factors e.g. fatigue, which was reported to affect a 
physicians’ performance in many studies [1]. Constantly dealing with large amounts of data in 
different modalities is the norm. This is where machines offer their computational advantage 
as they can easily digest enormous quantities of data. Machine learning (ML) can be 
understood as a fundamental technology required to meaningfully process data that exceeds 
the capacity and comprehensive abilities of a human brain [2]. 
Artificial intelligence (AI) is often described as software allowing computer systems 
to perform tasks that are believed to require human intelligence. This is an umbrella term for 
many computational methods, some of which are recently attracting a lot of attention from the 
medical community. The advantages of a computerized approach over medical data analysis 
include lowered cost, increased speed and accessibility. In this review, some of the most 
prominent and promising practical applications of ML techniques in the field of cardiology  
are described. Also discussed are the potential safety issues related to the use of AI in clinical 
practice. 
Recent years have triggered a rapid growth in ML-related publications in all fields of 
medicine. The growth in interest in this area has been exponential as illustrated in Figure 1. 
Although the greatest progress in the field of AI happened over the last 10 years, the onset of 
AI can be traced back much earlier. The historical aspect of AI is discussed in more detail by 
Benjamins et al. [3]. 
Owing to the popularity of this topic, many reviews have been published with the aim 
of familiarizing the reader with the relatively new concepts in AI methods [2,4]. The specific 
applications of AI in cardiology have also been reviewed [3, 5–8]. Some of these papers 
focused on general usage scenarios of ML in cardiology [9] while others provided deeper 
insights into specific applications e.g. image analysis [10–12]. Some reviews covered 
technical aspects of various ML methods in greater detail [5]. Although many reviews have 
already been published, the field of medical AI is progressing very rapidly, and new research 
is published almost every day. This paper aims to present some of the most recent 
applications of AI in cardiology and discusses many safety concerns, which have recently 
received a lot of attention from the scientific community. 
 
Overview of artificial intelligence and machine learning 
The most commonly used terms “artificial intelligence” (AI) and “machine learning” 
(ML) are interrelated and are sometimes used in a similar context. However, they do require 
some disambiguation. Figure 2 presents how the most common techniques relate to each 
other. 
Artificial intelligence is often described as human-like intelligence demonstrated by a 
machine. This is a broad term that applies to systems based on ML as well as to expert 
systems and robotics. ML, by contrast, is a group of algorithms that allow a computer to learn 
to perform a specific task based on several examples. 
Machine learning algorithms are rooted in so-called traditional statistics. The simplest 
ML model can be based on logistic regression. However, more sophisticated methods 
including decision trees, support vector machines, random forests or neural networks that 
have the advantage of handling complex and non-linear relationships within the data while 
avoiding ‘improper dichotomization’ [5]. The most recently developed techniques include 
deep neural networks, also called deep learning. These algorithms allow for the rapid progress 
of image recognition, natural language processing, speech recognition and are widely used in 
the latest medical research [2, 13].  
 
Machine learning workflow 
There are three standard ways in which any machine-learning model can be trained: 
supervised, unsupervised and reinforced (so called reinforcement learning). The first 
paradigm takes advantage of a set of labeled data — examples of input data along with correct 
answers. The dataset is divided into training, validation and test sets at an early stage of data 
manipulation. The training set is used to create the model — this is the data the algorithm 
learns from. To assess the process of learning, the validation set is used. During the process of 
training, the performance of the model is assessed multiple times on the validation set and the 
model improves gradually. In some cases, samples from the training and validation sets are 
shuffled in a process called cross-validation. The test set is used when the training process is 
finished to assess model performance on unseen data. The choice of sizes of these sets is 
based on available resources and depends on several factors. Generally, the more cases there 
are in the training set, the better the model performs. However, at some point, the model 
performance reaches a plateau and does not improve significantly despite adding new cases. 
In a cornerstone study by Gulshan et al. [14], such a plateau was observed when using 60,000 
or more training images. On the other hand, the more cases that are held out in the 
test/validation sets, the narrower are the confidence intervals of a classifiers’ performance 
measures. When comparing two classifiers, the absolute number of cases needed in the test set 
can be estimated using statistical test power calculations [15]. Figure 3 illustrates the typical 
workflow for the application of AI in a prediction task.  
Interestingly, through unsupervised learning, it is possible to find patterns in the data 
without explicitly specifying what we are looking for. Various algorithms including 
hierarchical clustering, k-means clustering, neural networks, and many others can allow for 
the self-organization of the data. This is usually a starting point for analyses using 
conventional statistical methods. Unsupervised learning imitates human intelligence and the 
ability to draw conclusions based on the data alone.   
In the last paradigm, reinforcement learning, the learning process is continuous — the 
system works and learns from its own mistakes. These kinds of models are very successful in 
various applications (a program based on reinforcement learning [AlphaGo] beat the world 
champion in the game of ‘Go’ in 2017 — a task believed to be impossible for a machine) 
[16]. Despite being a great area of research, reinforcement learning has not been widely 
adopted in medical applications yet. As the model can modify its behavior over time, it has 
not been well established on how to ensure its clinical safety.  
 
Deep learning 
Deep neural networks, often referred to as deep learning allowed for a great leap 
forward in image recognition and natural language processing including automatic translation, 
voice recognition, and many other breakthroughs [17]. The image recognition techniques 
proved to be very useful in the analysis of medical images and physiological signals like 
electrocardiogram (ECG). The core concept lies in mimicking the way the human visual 
cortex works.  
Bizopoulos and Koutsouries [18] in their systematic review provided a detailed 
overview of the applications of deep learning in the field of cardiology with insights into the 
various methodologies and architectures used. They also made a listing of publicly available 
datasets that can be used for developing and benchmarking ML models.  
In this review, working principles and detailed properties of various ML algorithms 
are not discussed. Anyone interested in acquiring more detailed knowledge can refer to the 
article by Johnson et al. [5] where they describe the working principles of a number of ML 
methods along with their advantages and disadvantages. 
 
How can AI contribute to the area of cardiology? 
In many usage scenarios AI is designed to mimic actions typically performed by a 
doctor — it recognizes a disease in images or classifies some other signals to provide an 
answer that a trained specialist would base on the same data. However, one of the most 
inspiring applications of AI is where it can provide insights into the data that were not 
anticipated by finding patterns in high-dimensional data. A canonical example is the study of 
diabetic retinopathy images — the algorithm was designed to determine a patient’s 
cardiovascular risk based on an eye fundus image alone [19]. It turned out that the model was 
not only able to predict the total risk but also could determine the individual risk factors (sex, 
age, systolic blood pressure) to a degree of precision not reported before. Such results not 
only have a great potential for practical application but can also guide basic research given 
that sex differences in eye fundus are not yet fully understood.  
Another example of an ML model analyzes data in a different way than doctors are 
used to doing was presented by researchers from the Mayo Clinic [20]. Using a deep neural 
network trained on over 600,000 ECGs, they showed that it was possible to identify the 
‘electrocardiographic signature’ of paroxysmal atrial fibrillation in a standard 12-lead 10-
second ECG taken during sinus rhythm. They achieved an area under the receiver-operating 
curve of 0.9, proving this method could be potentially useful for population-wide AF 
screening. 
Soon the same team went even further and developed a model able to predict the 
presence of asymptomatic left ventricular dysfunction (ALVD) using the digital data from 
resting ECGs and trans-thoracic echocardiograms of 97,827 subjects [21]. Then, they 
validated it prospectively [22]. Currently, they are running a randomized clinical trial to 
investigate the usefulness of the proposed approach for screening for ALVD in primary care 
settings [23]. 
Unsupervised learning can be of great value when it comes to discovering new 
patterns and structures in data. In this technique, data is fed to an algorithm without labels and 
then becomes self-organized into multiple subgroups based on similarities between data 
points. This allows for the identification of new, unknown features and can drive further 
research. Shah et al used this approach [24] to prospectively study patients with diagnosed 
heart failure with preserved ejection fraction. By applying an unsupervised ML method called 
hierarchical cluster analysis, they were able to classify the subjects into three distinctive 
phenogroups that differed significantly in terms of outcomes. Another study [25] used a 
similar methodology to identify groups with a potential substrate for heart failure among 
hypertensive patients. These are good examples of how unsupervised learning techniques can 
provide a starting point for further analyses using supervised methods and inferential 
statistics. Such an approach may lead to the development of more specific treatment strategies 
according to the paradigm of precision medicine [26]. Very recently, Wang et al. [27] used an 
unsupervised autoencoder based on a deep learning algorithm to represent data from 
electronic health records and compared the classification based on these learned features with 
more conventional approaches.  
Table 1 presents a non-exhaustive list of AI research examples in the field of 
cardiology. This list is intended to give a general overview of possible areas of application 
and demonstrates how AI can improve various aspects of patient care in cardiology. The 
studies are grouped by the type of input data used (imaging data, ECG signal, clinical data). A 
brief description of the methodology is provided for each example. 
 
AI — hype or hope? 
Artificial intelligence has brought as much hope as fear even long before it became a 
reality. It is even argued that there is little evidence that it improves patient outcomes [64]. 
This section aims to illustrate some of the potential threats and difficulties that need to be 
overcome to ensure that medical AI benefits us all.  
 
AI safety 
What if a machine makes the wrong diagnosis? There are indeed safety concerns 
regarding the use of automated decision support systems. One of the issues that can affect the 
practical safety of an AI-based classification tool is the ‘hidden stratification’ of the dataset. 
This term was coined by researchers from the University of Adelaide and Stanford University 
[65] and describes a situation in supervised learning when, due to the coarse labeling of the 
data (for example normal vs. abnormal), there are some unrecognized subgroups within each 
label. Obviously, the machine cannot learn a class if it was not labeled specifically. The 
system can learn to recognize the more general label quite well while underperforming on 
some specific subtype that was not given a separate label despite different clinical 
characteristics (Fig. 4). As a result, the reported performance measures can be good, albeit do 
not reflect the actual clinical usefulness of the model. If the ‘hidden’ subtype is a more 
dangerous one, it is clear that the consequences could be serious. This leads to a situation 
contrary to the common sense of a doctor, who intuitively tries to exclude the most dangerous 
diagnoses first (even if they are not common). Simply phrased, AI trained by means of an 
improperly labeled dataset may seem to make few mistakes but may still fail in very 
important cases, while a doctor could still make mistakes in less important cases. The 
difference between a computer and a human being lies in the fact that humans understand the 
consequences of their decisions and try to do their best when they know that the stakes are 
high.  
Oakden-Rayner et al. [65] recognize the underlying mechanisms that cause these types 
of errors and they propose several methods to address this issue. The main reason why hidden 
stratification can occur is the improper labeling of the data (oversimplified labels). One 
method proposed to prevent the hidden stratification is the use of exhaustive prospective data 
labeling in a tree-like fashion that includes classes and finer subclasses, which may be 
additionally weighted given their clinical significance. Such a predefined schema could even 
be standardized by an external authority and serve for benchmarking the models designed for 
a similar task. One of the studies that used such a well-defined label structure, including 
coarse classes and more fine-graded subclasses, was used in the classification of skin lesion 
images [66]. 
 
Explainable AI 
Although often perceived as a black-box, there are various methods to provide insights 
into how ML methods generate their predictions. In contrast to traditional, regression-based 
statistical inference, more complex methods can model real-world relationships in a better 
way. In such cases, ML methods can even be used as a source of analytical insights into the 
data by providing information on how each variable affects the outcome.  
The explanatory features of AI also have their legal aspects. The General Data 
Protection Regulation (GPDR), which was introduced in the European Union in 2016, 
imposes constraints on how personal data can be used in automated decision systems and so-
called ‘profiling’, including healthcare applications. These regulations form additional safety 
measures for the protection of privacy while also guaranteeing the ‘right to explanation’ [67]. 
They introduce several practical challenges for the design and practical deployment of 
machine-learning algorithms. Providing explanatory features (i.e. a way in which the model 
can communicate what led to its final conclusion) can be seen as an additional safety measure. 
Such an explanation can be provided in a form of a graph illustrating the importance of 
features, a heatmap (in the case of images) or a full written report, similar to the one that a 
physician would write [68]. A very recent study proved that explanatory features increases a 
doctor’s trust as a decision support tool and a willingness to follow its advice. However, there 
is no evidence that presenting a prediction alongside such an explanation leads to a better 
clinical outcome than showing the prediction alone. In fact, automation bias could 
theoretically even lead to worse clinical outcomes [69]. 
 
Is the AI biased? 
As machine-learned models are finding their way into routine medical practice, 
concerns are raised regarding the potential statistical bias (that might be introduced into the 
model) as well as the automation bias (related to the use of AI tools by doctors).  
The source of statistical bias lies in the data that was used to train the algorithm, either 
because it was not representative of the population or because it contained non-ignorable (not 
randomly distributed) missing values or additional data points (e.g. given that doctors are 
more likely to perform additional tests if the patient is in poor condition) [70–72]. This kind 
of bias is nothing new and has always been a concern for prediction models. The use of AI 
decision support tools can also introduce so-called ‘automation bias’ which relates to the 
behavioral aspects seen in automation systems used by humans. This topic was discussed in 
great detail in the paper by Parasuraman and Manzey [69].  
Automation bias is caused by a natural human tendency to pay less attention to 
automated tasks when under pressure. This happens because the users tend to ascribe greater 
power and authority to automated aids than to other sources of advice. In other words, a 
‘human in the loop’ is likely to follow the advice of AI, even if other available sources and his 
own knowledge contradict that. 
 
Clinical trials — are we there yet? 
Despite the rapid development and growing interest in the applications of ML methods 
in medicine, the majority of up-to-date publications are based on experiments in laboratory 
settings. There have been very few studies which indicate that using AI-based tools improves 
patient outcomes.  
The fact that a new drug works as expected in pre-clinical experiments does not prove 
its usefulness and safety. Similarly, studies have shown that achieving good results when 
testing a ML model in a controlled environment does not necessarily mean that it will 
improve patient outcomes [73] when used in standard practice. Various psychological factors 
affect a doctors’ response to the suggestions of computer systems and it is known that the 
presence of such a system can sometimes decrease their vigilance resulting in lower 
sensitivity. This can be well illustrated by the adoption of computer-aided detection for 
mammography — a sort of AI algorithm developed in the 1990s in the United States, aimed 
to assist radiologists in assessing mammograms. The algorithm had been developed before the 
‘deep learning era’ but it seemed to improve breast cancer diagnostics in laboratory settings. 
It was reimbursed by medical insurers who decided to pay more for assessing radiograms 
using computer-aided detection. However, when assessed in clinical settings, it did not only 
fail to improve radiologists’ performance but also decreased their sensitivity [74]. 
Up till now there have been very few clinical trials related to the use of AI-tools in 
medicine [75]. One such study proved that AI-assisted colonoscopy could help detect more 
malignant lesions but it also increased the number of unnecessary biopsies [76]. Another 
example is the EAGLE trial that was mentioned earlier [23]. A recent randomized control trial 
evaluated the application of an early warning system against hypotension during elective 
surgery [77]. Despite many studies conducted prospectively and on a large scale, we still 
know very little about how the actual application of AI in healthcare affects patients and 
doctors. Well-designed randomized clinical trials are needed to prove the safety and 
usefulness of medical AI in real-world settings.  
 Summary 
Artificial intelligence is anticipated to shape the new decade and bring meaningful 
changes to society, the economy, healthcare and people’s lifestyles. For these reasons, AI has 
been hailed as the fourth industrial revolution [78]. The ‘technology of the future’ is already 
here but converting this into an actual benefit for patients is a task that lies with clinicians. 
Recent years have seen numerous studies that took advantage of various breeds of AI. In 
many cases algorithms were designed and validated using the retrospective data only. We are 
now entering the phase in which ML models need to be tested prospectively and in clinical 
settings. Knowing how data-hungry ML models are, it is important to develop and adopt the 
standards of data acquisition that make it easier to cooperate on multi-center projects. On the 
other hand, we also need to standardize the tools used to monitor the performance of AI-based 
systems. 
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Table 1. Examples of artificial intelligence applications in cardiology. 
Diagnostic 
modality/t
ype of data 
used 
Application Study methodology Reference(s) 
Echocardio
graphy 
Identification of 
echocardiographic views 
A convolutional neural network was used to 
distinguish between 15 standard echocardiographic 
views with an accuracy of 97.8% 
Madani et al. 
2018 [28] 
Differentiating CP from RCM The model was based on an associative memory 
classifier algorithm. Echocardiograms of 50 
patients with CP, 44 with RCM and 47 controls 
were used to train the model 
Sengupta et al. 
2016 [29] 
Fully automated 
echocardiogram interpretation 
and detection of selected clinical 
conditions  
A convolutional neural network was trained on 
14,035 echocardiograms to identify views, perform 
the segmentation of heart chambers, determine 
ejection fraction and other measurements and 
finally to detect a number of clinical conditions 
(cardiomyopathy, cardiac amyloidosis and 
pulmonary arterial hypertension with the C 
statistics of 0.93, 0.87, and 0.85, respectively) 
Zhang et al. 
2018 [30] 
CT Calculating calcium score based 
on CT-angiography scans. (May 
obviate the need for a separate 
calcium Score scan; thus, 
reducing the radiation dose) 
The authors designed a convolutional neural 
network that processes each of the three axes (axial, 
saggital, coronal) separately. The model was trained 
using a total of 250 hand-annotated exams 
Wolterink et 
al. 2016 [31] 
Calculating FFR values based 
on cardiac CT 
The models created using convolutional neural 
networks have some advantages (including shorter 
computation times) over the clinically validated 
approach based on computational fluid dynamics 
while maintaining a non-inferior performance 
Coenen et al. 
2018 [32] 
Tesche et al. 
2018 [33]  
Predicting all-cause mortality 
based on cardiac CT and clinical 
variables 
25 clinical and 44 CT-derived variables of over 
10,000 patients were used to train the iterative Logit 
Boost algorithm. The resulting model could predict 
a 5-year mortality rate with the c-statistic of 0.79 
Motwani et al. 
2017 [34] 
CT scan denoising — improving 
readability of acquired images 
while also reducing the 
necessary radiation exposure 
The authors obtained scans using n 20% and 100% 
of the clinical radiation dose. The model based on 
generative adversarial network architecture was 
trained to generate full-quality images based on the 
images acquired with a low radiation dose 
Wolterink et 
al. 2017 [35] 
Detecting significant coronary 
lesions based on the motion of 
the left ventricle myocardium 
The complex model consisted of a convolutional 
neural network (for the myocardium segmentation), 
an unsupervised convolutional autoencoder (for the 
extraction of the myocardium characteristics) and a 
support vector classifier 
Zreik et al. 
2018 [36] 
Predicting cardiac death after 
myocardial perfusion SPECT 
imaging 
A total of 122 features (both the clinical data and 
variables derived from SPECT scans) of over 8,000 
patients were used to train the multiple ML models. 
Haro Alonso 
et al. 2019 
[37] 
A model based on SVM outperformed baseline 
logistic regression as well as random forests 
Detecting the presence and 
location of significant coronary 
artery stenosis based on SPECT 
images 
In these multicenter studies, all patients underwent 
myocardial perfusion imaging and coronary 
angiography within 6 months. A deep neural 
network was trained to predict obstructive coronary 
disease based on SPECT myocardial perfusion 
images 
Betancur et al. 
2018, 2019 
[38, 39] 
Predicting major adverse cardiac 
events using a combination of 
clinical data and myocardial 
perfusion SPECT images 
28 clinical variables, 17 stress test variables, and 25 
imaging variables of 2,619 patients were analyzed. 
The ML model was based on the Logit Boost 
algorithm 
Betancur et al. 
2018 [40] 
MRI Segmentation of heart 
structures, automatic 
measurement of the left 
ventricular end-diastolic volume 
and other values 
A fully convolutional neural network was trained 
using pixel-annotated MRI images from 4,875 
patients. The model was able to perform highly 
accurate automatic measurements and delineation 
of heart structures 
Bai et al. 2018 
[41] 
Detecting abnormalities of aortic 
valve 
The authors developed a novel strategy for training 
medical ML models using unlabeled imaging data. 
They created a weakly-supervised model capable of 
diagnosing aortic valve abnormalities in MRI scans 
Fries et al. 
2019 [42] 
Objective assessment of atrial 
scarring for patients with AF 
The authors developed a complete pipeline for atrial 
scarring segmentation. A classification algorithm 
based on SVM was used 
Yang et al. 
2018 [43] 
Diagnosing pulmonary 
hypertension based on 
cardiovascular MRI 
The model was trained using 220 MRI scans of 
patients who had also underwent right heart 
catheterization 
Swift and al. 
2020 [44] 
Coronary 
angiograph
y 
Segmentation of coronary 
vessels from angiograms 
The model was based on a U-Net architecture (a 
type of a deep neural network). 3,302 still images of 
coronary arteries were used to train the model 
Yang et al. 
2019 [45] 
ECG signal Diagnosing ALVD using ECG 
only 
The ECG signals and echocardiographic data of 
97,829 patients were used (the time between ECG 
and echocardiography was less than 2 weeks). A 
model based on a neural network could predict 
ALVD with a sensitivity and specificity of 86%. 
The initial study laid the groundwork for a 
prospective evaluation and the ongoing clinical trial 
Attia et al. 
2019 [21,22] 
Detecting paroxysmal AF based 
on contemporary 12-lead ECG 
taken on sinus rhythm 
The authors have shown that it is possible to 
identify an ‘electrocardiographic signature’ of 
paroxysmal AF in a routine 10-second 12-lead 
ECG. The use of a convolutional neural network 
allowed the detection of signals invisible to the 
human eye 
Attia et al. 
2019 [20] 
Predicting the development of 
moderate to severe mitral 
regurgitation based on 12-lead 
The AUROC in external validation of 10,865 cases 
was 0.877. Positively diagnosed patients also had a 
higher chance of developing mitral regurgitation in 
the future. Additionally, the authors used 
visualization techniques that helped understand 
Kwon et al. 
2020 [46] 
ECG using a deep neural 
network 
which parts of an ECG influence the decisions of 
their algorithm 
EHR  Predicting cardiovascular risk 
based on records from primary 
care 
30 variables identified within the primary health 
records of 378,256 patients were analyzed. The 
authors used a number of ML algorithms including 
logistic regression, random forests and neural 
networks 
Weng et al. 
2017 [47] 
Predicting the in-hospital 
mortality rate, re-admission and 
a prolonged length of stay based 
on raw electronic health records 
Multi-year medical histories stored in EHRs linked 
to 216,221 hospitalizations were converted into 
over 46 billion data points, each representing a 
result, clinical event, physician’s note etc. An 
ensemble of three types of neural networks was 
trained to predict various clinical endpoints with 
high accuracy 
Rajkomar et 
al. 2018 [48] 
Predicting the probability of in-
hospital death at the time of 
admission 
The model was crated based on retrospective data 
but validated prospectively and externally in 3 
different hospitals. A total number of over 75,000 
admissions were used to create and validate the 
model. The AUROC was 0.86 in an external 
validation. 
Brajer et al. 
2020 [49] 
Clinical 
data 
Predicting readmission of 
patients with heart failure  
An EHR-wide feature selection (over 4,000 
variables were considered) and a model based on 
logistic regression was developed to predict the 30-
day readmission rates 
Shameer et al. 
2017 [50] 
Predicting long and short-term 
mortality after ACS 
In these papers various ‘classical’ ML models 
(support vector machines, random forests, xgboost) 
were developed to predict mortality after acute 
coronary syndromes using clinical data 
Shouval et al. 
2017 [51] 
Wallert et al. 
2017 [52] 
Pieszko et al. 
2018, 2019 
[53, 54] 
Predicting the risk of major 
adverse cardiac events and 
bleeding after ACS 
The data on over 24,000 patients with ACSs were 
pooled from 4 randomized controlled trials. The 
ML algorithm demonstrated superiority over 
traditional risk scores 
Gibson et al. 
2020 [55] 
Selecting the right patients for 
cardiac resynchronization 
therapy 
Classical ML algorithms were applied to predict 
survival after CRT implantation. The model based 
on random forest showed the best performance 
Kalscheur et 
al. 2018 [56] 
ACS — acute coronary syndrome; AF — atrial fibrillation; ALVD — asymptomatic left ventricular dysfunction; 
CP — constrictive pericarditis; CT — computed tomography; HER — electronic health records; ECG — 
electrocardiogram; FFR — fractional flow reserve; ML — machine learning; MRI — magnetic resonance 
imaging; RCM — restrictive cardiomyopathy; SVM — support vector machines; SPECT — single-photon 
emission computed tomography  
 
Figure 1. The number of publications related to artificial medicine over the last 15 years. 
Each series represents the number of results found in PubMed matching the given phrase by 
the year of publication. 
 
Figure 2. The machine learning and statistical methods and their relation to each other. On 
the right: three most common machine learning paradigms. 
 
Figure 3. The workflow for a typical task for medical artificial intelligence — supervised 
learning. 
 
Figure 4. Hidden stratification explained using a hypothetical model for electrocardiogram 
(ECG) abnormality prediction. The model is trained to detect any abnormality in ECG and it 
works very well, having high specificity and sensitivity. However, the errors are not equally 
distributed across possible abnormal conditions. Some of the errors are detected very well 
while others are ignored by the algorithm. Such cases are rare so the fact that the model does 
not recognize these abnormal conditions does not significantly affect the overall performance 
in detecting any ECG abnormality. 
 




